Jandacva.ge
Deputy Minister of Healthcare of Georgia Mr. Valeri Kvaratskhelia and the Vice President, Greg Alton has signed an agreement between Georgian government and pharmaceutical giant Gilead.
Long term contract will provide Georgia with continuous number of C hepatitis medications until absolute elimination.
John Martin, General director of the United States Centers for Disease Control, representatives of Spain Embassy and other officials attended the ceremony.
Gilead chose Georgia as a test site partly because the nation has the world’s third-largest number of HCV-positive people, behind Egypt and Mongolia. The country’s small population and pre-existing medical infrastructure also made it ideal for the experiment. An estimated 7 percent of the nearly 5 million adults in Georgia have a chronic HCV infection.
The goal of the study is to prove to governments and health agencies worldwide how much investment into new drugs can change the landscape of hep C.
